Calcific aortic stenosis (original) (raw)

• Rajamannan, N. M. et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group executive summary: calcific aortic valve disease — 2011 update. Circulation 124, 1783–1791 (2011). A good review of the state of knowledge and future research directions for calcific aortic valve disease (in 2011).
  Article PubMed PubMed Central Google Scholar
• Go, A. S. et al. Executive summary: heart disease and stroke statistics — 2013 update: a report from the American Heart Association. Circulation 127, 143–152 (2013).
  Article PubMed Google Scholar
• Nishimura, R. A. et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, e57–e185 (2014). The most recent version of the clinical guidelines for the management of valvular heart disease, including AS.
  Article PubMed Google Scholar
• Vahanian, A. et al. Guidelines on the management of valvular heart disease Joint Task Force on the management of valvular heart disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 33, 2451–2496 (2012).
  Article PubMed Google Scholar
• Roberts, W. C. & Ko, J. M. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111, 920–925 (2005).
  Article PubMed Google Scholar
• Bosse, Y., Mathieu, P. & Pibarot, P. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. J. Am. Coll. Cardiol. 51, 1327–1336 (2008).
  Article CAS PubMed Google Scholar
• Michelena, H. I. et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 306, 1104–1112 (2011).
  Article CAS PubMed Google Scholar
• Michelena, H. I. et al. Bicuspid aortic valve: dentifying knowledge gaps and rising to the challenge from the international bicuspid aortic valve consortium (BAVCon). Circulation 129, 2691–2704 (2014). A review of the diagnosis, complications and management of bicuspid aortic valve syndrome.
  Article PubMed PubMed Central Google Scholar
• Stewart, B. F. et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29, 630–634 (1997).
  Article CAS PubMed Google Scholar
• Cosmi, J. E. et al. The risk of the development of aortic stenosis in patients with “benign” aortic valve thickening. Arch. Intern. Med. 162, 2345–2347 (2002).
  Article PubMed Google Scholar
• Coffey, S., Cox, B. & Williams, M. J. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 63, 2852–2861 (2014).
  Article PubMed Google Scholar
• Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005–1011 (2006). An epidemiology study reporting the prevalence of valvular heart disease, including calcific AS, in the general population.
  Article PubMed Google Scholar
• Eveborn, G. W., Schirmer, H., Heggelund, G., Lunde, P. & Rasmussen, K. The evolving epidemiology of valvular aortic stenosis. The Tromso Study. Heart 99, 396–400 (2013).
  Article PubMed Google Scholar
• Lindroos, M., Kupari, M., Heikkila, J. & Tilvis, R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21, 1220–1225 (1993).
  Article CAS PubMed Google Scholar
• Danielsen, R., Aspelund, T., Harris, T. B. & Gudnason, V. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavik study. Int. J. Cardiol. 176, 916–922 (2014).
  Article PubMed PubMed Central Google Scholar
• Osnabrugge, R. L. et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. 62, 1002–1012 (2013).
  Article PubMed Google Scholar
• Probst, V. et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 113, 856–860 (2006).
  Article PubMed Google Scholar
• Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur. Heart J. 24, 1231–1243 (2003). A large European survey describing the clinical management of valvular heart disease and adherence to guidelines in real-life clinical practice.
  Article PubMed Google Scholar
• Iung, B. & Vahanian, A. Degenerative calcific aortic stenosis: a natural history. Heart 98 (Suppl. 4), iv7–iv13 (2012).
  Article PubMed Google Scholar
• Demirbag, R., Sade, L. E., Aydin, M., Bozkurt, A. & Acarturk, E. The Turkish registry of heart valve disease. Turk Kardiyol. Dern. Ars. 41, 1–10 (2013).
  Article PubMed Google Scholar
• Sliwa, K. et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur. Heart J. 31, 719–727 (2010).
  Article PubMed Google Scholar
• Freeman, R. V. & Otto, C. M. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111, 3316–3326 (2005).
  Article PubMed Google Scholar
• Rajamannan, N. M., Bonow, R. O. & Rahimtoola, S. H. Calcific aortic stenosis: an update. Nat. Clin. Pract. Cardiovasc. Med. 4, 254–262 (2007).
  Article CAS PubMed Google Scholar
• Chen, J. H. & Simmons, C. A. Cell–matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ. Res. 108, 1510–1524 (2011).
  Article CAS PubMed Google Scholar
• Schoen, F. J. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 118, 1864–1880 (2008).
  Article PubMed Google Scholar
• Taylor, P. M., Allen, S. P. & Yacoub, M. H. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J. Heart Valve Dis. 9, 150–158 (2000).
  CAS PubMed Google Scholar
• Latif, N., Sarathchandra, P., Chester, A. H. & Yacoub, M. H. Expression of smooth muscle cell markers and co-activators in calcified aortic valves. Eur. Heart J. 36, 1335–1345 (2015).
  Article CAS PubMed Google Scholar
• Steiner, I., Kasparova, P., Kohout, A. & Dominik, J. Bone formation in cardiac valves: a histopathological study of 128 cases. Virchows Arch. 450, 653–657 (2007).
  Article PubMed Google Scholar
• Cote, N. et al. Inflammation is associated with the remodeling of calcific aortic valve disease. Inflammation 36, 573–581 (2013).
  Article CAS PubMed Google Scholar
• Helske, S. et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur. Heart J. 27, 1495–1504 (2006).
  Article CAS PubMed Google Scholar
• Mathieu, P. & Boulanger, M. C. Basic mechanisms of calcific aortic valve disease. Can. J. Cardiol. 30, 982–993 (2014).
  Article PubMed Google Scholar
• Price, P. A., Toroian, D. & Chan, W. S. Tissue-nonspecific alkaline phosphatase is required for the calcification of collagen in serum: a possible mechanism for biomineralization. J. Biol. Chem. 284, 4594–4604 (2009).
  Article CAS PubMed Google Scholar
• Price, J. et al. Prosthesis–patient mismatch is less frequent and more clinically indolent in patients operated for aortic insufficiency. J. Thorac Cardiovasc. Surg. 138, 639–645 (2009).
  Article PubMed Google Scholar
• Rattazzi, M. et al. Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification. Atherosclerosis 237, 568–576 (2014).
  Article CAS PubMed Google Scholar
• Hinton, R. B. et al. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ. Res. 98, 1431–1438 (2006).
  Article CAS PubMed Google Scholar
• Satta, J. et al. Progression of human aortic valve stenosis is associated with tenascin-C expression. J. Am. Coll. Cardiol. 39, 96–101 (2002).
  Article CAS PubMed Google Scholar
• Pawade, T. A., Newby, D. E. & Dweck, M. R. Calcification in aortic stenosis: the skeleton key. J. Am. Coll. Cardiol. 66, 561–577 (2015).
  Article PubMed Google Scholar
• Abdelbaky, A. et al. Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study. Atherosclerosis 238, 165–172 (2015).
  Article CAS PubMed Google Scholar
• O'Brien, K. D. et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of ‘degenerative’ valvular aortic stenosis. Arterioscler. Thromb. Vasc. Biol. 16, 523–532 (1996).
  Article CAS PubMed Google Scholar
• Mohty, D. et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler. Thromb. Vasc. Biol. 28, 187–193 (2008).
  Article CAS PubMed Google Scholar
• Olsson, M., Thyberg, J. & Nilsson, J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler. Thromb. Vasc. Biol. 19, 1218–1222 (1999).
  Article CAS PubMed Google Scholar
• Cote, C. et al. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis. Heart 94, 1175–1180 (2008).
  Article CAS PubMed Google Scholar
• Miller, J. D. et al. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J. Am. Coll. Cardiol. 52, 843–850 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Liberman, M. et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler. Thromb. Vasc. Biol. 28, 463–470 (2008).
  Article CAS PubMed Google Scholar
• Parhami, F. et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler. Thromb. Vasc. Biol. 17, 680–687 (1997).
  Article CAS PubMed Google Scholar
• Tsimikas, S. & Witztum, J. L. The role of oxidized phospholipids in mediating lipoprotein (a) atherogenicity. Curr. Opin. Lipidol. 19, 369–377 (2008).
  Article CAS PubMed Google Scholar
• Dube, J. B., Boffa, M. B., Hegele, R. A. & Koschinsky, M.L. Lipoprotein (a): more interesting than ever after 50 years. Curr. Opin. Lipidol. 23, 133–140 (2012).
  Article CAS PubMed Google Scholar
• Thanassoulis, G. et al. Genetic associations with valvular calcification and aortic stenosis. N. Engl. J. Med. 368, 503–512 (2013). This is the first large genetic study to show an association between the LPA gene and incident AS.
  Article CAS PubMed PubMed Central Google Scholar
• Kamstrup, P. R., Tybjaerg-Hansen, A. & Nordestgaard, B. G. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J. Am. Coll. Cardiol. 63, 470–477 (2014).
  Article CAS PubMed Google Scholar
• Arsenault, B. J. et al. Lipoprotein(a) levels, genotype and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case–control cohort. Circ. Cardiovasc. Genet. 7, 304–310 (2014).
  Article CAS PubMed Google Scholar
• Capoulade, R. et al. Oxidized phospholipids, lipoprotein(a) and progression of aortic valve stenosis. J. Am. Coll. Cardiol. 66, 1236–1246 (2015).
  Article CAS PubMed Google Scholar
• Derbali, H. et al. Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. Am. J. Pathol. 176, 2638–2645 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Song, R. et al. Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler. Thromb. Vasc. Biol. 32, 2711–2720 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Mahmut, A. et al. Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling. Eur. J. Clin. Invest. 43, 570–578 (2013).
  Article CAS PubMed Google Scholar
• Osman, N. et al. Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans. Cardiovasc. Pathol. 22, 146–155 (2013).
  Article CAS PubMed Google Scholar
• Hung, M. Y., Witztum, J. L. & Tsimikas, S. New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)–lipoprotein-associated phospholipase A2-oxidized phospholipid axis. J. Am. Coll. Cardiol. 63, 478–480 (2014).
  Article PubMed Google Scholar
• Mahmut, A. et al. Elevated expression of Lp-PLA2 in calcific aortic valve disease: implication for valve mineralization. J. Am. Coll. Cardiol. 63, 460–469 (2014).
  Article CAS PubMed Google Scholar
• Mahmut, A. et al. Lp-PLA2 is associated with structural valve degeneration of bioprostheses. Eur. J. Clin. Invest. 44, 136–145 (2014).
  Article CAS PubMed Google Scholar
• Capoulade, R. et al. Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis. JACC Cardiovasc. Imaging 8, 26–33 (2015).
  Article PubMed Google Scholar
• Tellis, C. C. & Tselepis, A. D. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim. Biophys. Acta 1791, 327–338 (2009).
  Article CAS PubMed Google Scholar
• Lehti, S. et al. Modified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves. PLoS ONE 8, e65810 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bouchareb, R. et al. Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve. Circulation 132, 677–690 (2015).
  Article CAS PubMed Google Scholar
• Rogers, M. A. & Aikawa, E. Not a-so-little role for lipoprotein(a) in the development of calcific aortic valve disease. Circulation 132, 621–623 (2015).
  Article PubMed PubMed Central Google Scholar
• Nagy, E. et al. Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts. Circulation 123, 1316–1325 (2011).
  Article CAS PubMed Google Scholar
• Wirrig, E. E., Gomez, M. V., Hinton, R. B. & Yutzey, K. E. COX2 inhibition reduces aortic valve calcification in vivo. Arterioscler. Thromb. Vasc. Biol. 35, 938–947 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Mathieu, P., Bouchareb, R. & Boulanger, M. C. Innate and adaptive immunity in calcific aortic valve disease. J. Immunol. Res. 2015, 851945 (2015).
  Article PubMed PubMed Central Google Scholar
• Venardos, N. et al. Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation. J. Surg. Res. 190, 1–8 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• West, X. Z. et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972–976 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Winchester, R. et al. Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis. J. Immunol. 187, 1006–1014 (2011).
  Article CAS PubMed Google Scholar
• Yoshioka, M. et al. Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat. Med. 12, 1151–1159 (2006).
  Article CAS PubMed Google Scholar
• Charest, A. et al. Distribution of SPARC during the neovascularisation of degenerative aortic stenosis. Heart 92, 1844–1849 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Bosse, Y. et al. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal calcified stenotic human aortic valves. Circ. Cardiovasc. Genet. 2, 489–498 (2009).
  Article CAS PubMed Google Scholar
• Helske, S. et al. Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves. Arterioscler. Thromb. Vasc. Biol. 26, 1791–1798 (2006).
  Article CAS PubMed Google Scholar
• Aikawa, E. et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 119, 1785–1794 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Yu, Y. C., Boston, J. R., Simaan, M. A. & Antak, J. F. Minimally invasive estimation of systemic vascular parameters. Ann. Biomed. Eng. 29, 595–606 (2001).
  Article CAS PubMed Google Scholar
• Hsu, H., Shu, H. B., Pan, M. G. & Goeddel, D. V. TRADD–TRAF2 and TRADD–FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299–308 (1996).
  Article CAS PubMed Google Scholar
• Lee, H. L., Woo, K. M., Ryoo, H. M. & Baek, J. H. Tumor necrosis factor-α increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. Biochem. Biophys. Res. Commun. 391, 1087–1092 (2010).
  Article CAS Google Scholar
• Isoda, K., Matsuki, T., Kondo, H., Iwakura, Y. & Ohsuzu, F. Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB/c mice. Arterioscler. Thromb. Vasc. Biol. 30, 708–715 (2010).
  Article CAS PubMed Google Scholar
• Lai, C. F. et al. TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts. Endocrinology 153, 3897–3910 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Galeone, A. et al. Aortic valvular interstitial cells apoptosis and calcification are mediated by TNF-related apoptosis-inducing ligand. Int. J. Cardiol. 169, 296–304 (2013).
  Article PubMed Google Scholar
• El Husseini, D. et al. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease. J. Mol. Cell. Cardiol. 72, 146–156 (2014).
  Article CAS PubMed Google Scholar
• Wada, T., Nakashima, T., Hiroshi, N. & Penninger, J. M. RANKL–RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 12, 17–25 (2006).
  Article CAS PubMed Google Scholar
• Kaden, J. J. et al. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulate aortic valve calcification. J. Mol. Cell. Cardiol. 36, 57–66 (2004).
  Article CAS PubMed Google Scholar
• Weiss, R. M. et al. Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. PLoS ONE 8, e65201 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Demer, L. L. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int. J. Epidemiol. 31, 737–741 (2002).
  Article PubMed Google Scholar
• Skolnick, A. H., Osranek, M., Formica, P. & Kronzon, I. Osteoporosis treatment and progression of aortic stenosis. Am. J. Cardiol. 104, 122–124 (2009).
  Article PubMed Google Scholar
• Osako, M. K. et al. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ. Res. 107, 466–475 (2010).
  Article CAS PubMed Google Scholar
• Helske, S. et al. Induction of local angiotensin II-producing systems in stenotic aortic valves. J. Am. Coll. Cardiol. 44, 1859–1866 (2004).
  Article CAS PubMed Google Scholar
• O'Brien, K. D. et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 106, 2224–2230 (2002).
  Article CAS PubMed Google Scholar
• Cote, N. et al. Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis. Int. J. Cardiol. 145, 444–449 (2010).
  Article PubMed Google Scholar
• Fujisaka, T. et al. Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice. Atherosclerosis 226, 82–87 (2013).
  Article CAS PubMed Google Scholar
• Arishiro, K. et al. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J. Am. Coll. Cardiol. 49, 1482–1489 (2007).
  Article CAS PubMed Google Scholar
• Cote, N., Couture, C., Pibarot, P., Despres, J. P. & Mathieu, P. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves. Eur. J. Clin. Invest. 41, 1172–1179 (2011).
  Article CAS PubMed Google Scholar
• Capoulade, R. et al. Impact of hypertension and renin–angiotensin system inhibitors in aortic stenosis. Eur. J. Clin. Invest. 43, 1262–1272 (2013).
  Article CAS PubMed Google Scholar
• Simmons, C. A., Grant, G. R., Manduchi, E. & Davies, P. F. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ. Res. 96, 792–799 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Holliday, C. J., Ankeny, R. F., Jo, H. & Nerem, R. M. Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 301, H856–H867 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Garg, V. et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437, 270–274 (2005). This is the first study to report that mutations in NOTCH1 cause both development of bicuspid aortic valve and calcification of aortic valve.
  Article CAS PubMed Google Scholar
• Nigam, V. & Srivastava, D. J. Notch1 represses osteogenic pathways in aortic valve cells. Mol. Cell. Cardiol. 47, 828–834 (2009).
  Article CAS Google Scholar
• Nus, M. et al. Diet-induced aortic valve disease in mice haploinsufficient for the Notch pathway effector RBPJK/CSL. Arterioscler. Thromb. Vasc. Biol. 31, 1580–1588 (2011).
  Article CAS PubMed Google Scholar
• Deregowski, V., Gazzerro, E., Priest, L., Rydziel, S. & Canalis, E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/β-catenin but not bone morphogenetic protein signaling. J. Biol. Chem. 281, 6203–6210 (2006).
  Article CAS PubMed Google Scholar
• Theodoris, C. V. et al. Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency. Cell 160, 1072–1086 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Caira, F. C. et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J. Am. Coll. Cardiol. 47, 1707–1712 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Shao, J. S. et al. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J. Clin. Invest. 115, 1210–1220 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Cola, C., Almeida, M., Li, D., Romeo, F. & Mehta, J. L. Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem. Biophys. Res. Commun. 320, 424–427 (2004).
  Article CAS PubMed Google Scholar
• Zhang, M. et al. MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells. J. Thorac Cardiovasc. Surg. 147, 1073–1080 (2014).
  Article CAS PubMed Google Scholar
• Bertazzo, S. et al. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat. Mater. 12, 576–583 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Bouchareb, R. et al. Mechanical strain induces the production of spheroid mineralized microparticles in the aortic valve through a RhoA/ROCK-dependent mechanism. J. Mol. Cell. Cardiol. 67, 49–59 (2014).
  Article CAS PubMed Google Scholar
• New, S. E. et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ. Res. 113, 72–77 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Hjortnaes, J., New, S.E. & Aikawa, E. Visualizing novel concepts of cardiovascular calcification. Trends Cardiovasc. Med. 23, 71–79 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Cote, N. et al. ATP acts as a survival signal and prevents the mineralization of aortic valve. J. Mol. Cell. Cardiol. 52, 1191–1202 (2012).
  Article CAS PubMed Google Scholar
• Mahmut, A., Boulanger, M. C., Bouchareb, R., Hadji, F. & Mathieu, P. Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor. Cardiovasc. Res. 106, 109–120 (2015).
  Article CAS PubMed Google Scholar
• Mathieu, P. et al. Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. J. Heart Valve Dis. 14, 353–357 (2005).
  PubMed Google Scholar
• Bouchareb, R. et al. Carbonic anhydrase XII in valve interstitial cells promotes the regression of calcific aortic valve stenosis. J. Mol. Cell. Cardiol. 82, 104–115 (2015).
  Article CAS PubMed Google Scholar
• Lorell, B. H. & Carabello, B. A. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102, 470–479 (2000).
  Article CAS PubMed Google Scholar
• Mewton, N., Liu, C. Y., Croisille, P., Bluemke, D. & Lima, J. A. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J. Am. Coll. Cardiol. 57, 891–903 (2011).
  Article PubMed Google Scholar
• Carroll, J. D. et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 86, 1099–1107 (1992).
  Article CAS PubMed Google Scholar
• Pagé, A. et al. Metabolic syndrome is associated with more pronounced impairment of LV geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J. Am. Coll. Cardiol. 55, 1867–1874 (2010).
  Article PubMed Google Scholar
• Lund, B. P. et al. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Am. J. Cardiol. 105, 1456–1460 (2010).
  Article PubMed Google Scholar
• Lindman, B. R. et al. The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis. Circ. Heart Fail 4, 286–292 (2011).
  Article PubMed PubMed Central Google Scholar
• Cramariuc, D. et al. Low-flow aortic stenosis in asymptomatic patients: valvular arterial impedance and systolic function from the SEAS substudy. JACC Cardiovasc. Imaging 2, 390–399 (2009).
  Article PubMed Google Scholar
• Cioffi, G. et al. Prognostic value of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 97, 301–307 (2011).
  Article PubMed Google Scholar
• Duncan, A. I. et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann. Thorac Surg. 85, 2030–2039 (2008).
  Article PubMed Google Scholar
• Rajappan, K. et al. Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries. Circulation 105, 470–476 (2002).
  Article PubMed Google Scholar
• Rajappan, K. et al. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation 107, 3170–3175 (2003).
  Article PubMed Google Scholar
• Julius, B. K. et al. Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation 95, 892–898 (1997).
  Article CAS PubMed Google Scholar
• Mutlak, D. et al. Frequency determinants and outcome of pulmonary hypertension in patients with aortic valve stenosis. Am. J. Med. Sci. 343, 397–401 (2012).
  Article PubMed Google Scholar
• Lancellotti, P. et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 126, 851–859 (2012).
  Article PubMed Google Scholar
• Dumesnil, J. G., Shoucri, R. M., Laurenceau, J. L. & Turcot, J. A mathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data. Circulation 59, 1024–1034 (1979).
  Article CAS PubMed Google Scholar
• Lancellotti, P. et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart 96, 1364–1371 (2010). This is a prospective study that shows the prognostic value of valve stenosis severity, valvulo-arterial impedance, left ventricular longitudinal function and left atrial dilation in patients with calcific aortic stenosis.
  Article PubMed Google Scholar
• Kusunose, K. et al. Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circ. Cardiovasc. Imaging 7, 938–945 (2014).
  Article PubMed Google Scholar
• Fernandez, B. et al. Bicuspid aortic valves with different spatial orientations of the leaflets are distinct etiological entities. J. Am. Coll. Cardiol. 54, 2312–2318 (2009).
  Article PubMed Google Scholar
• Mathieu, P. et al. The pathology and pathobiology of bicuspid aortic valves: state of the art and novel research perspective. J. Pathol. Clin. Res. 1, 195–206 (2015).
  Article PubMed PubMed Central Google Scholar
• Mohty, D. et al. Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin. Int. J. Cardiol. 142, 126–132 (2010).
  Article PubMed Google Scholar
• Aronow, W. S., Schwartz, K. S. & Koenigsberg, M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am. J. Cardiol. 59, 998–999 (1987).
  Article CAS PubMed Google Scholar
• Katz, R. et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis. Circulation 113, 2113–2119 (2006).
  Article PubMed Google Scholar
• Mohler, E. R., Sheridan, M. J., Nichols, R., Harvey, W. P. & Waller, B.F. Development and progression of aortic valve stenosis: atherosclerosis risk factors — a causal relationship? A clinical morphologic study. Clin. Cardiol. 14, 995–999 (1991).
  Article CAS PubMed Google Scholar
• Otto, C. M. et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 95, 2262–2270 (1997). This is one of the first prospective studies to describe the clinical and echocardiographic predictors of the progression and outcomes of calcific AS.
  Article CAS PubMed Google Scholar
• Livanainen, A. M., Lindroos, M., Tilvis, R., Heikkila, J. & Kupari, M. Natural history of aortic valve stenosis of varying severity in the elderly. Am. J. Cardiol. 78, 97–101 (1996).
  Article Google Scholar
• Palta, S., Pai, A. M., Gill, K. S. & Pai, R. G. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 101, 2497–2502 (2000).
  Article CAS PubMed Google Scholar
• Ngo, M. V., Gottdiener, J. S., Fletcher, R. D., Fernicola, D. J. & Gersh, B. J. Smoking and obesity are associated with the progression of aortic stenosis. Am. J. Geriatr. Cardiol. 10, 86–90 (2001).
  Article CAS PubMed Google Scholar
• Capoulade, R. et al. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. J. Am. Coll. Cardiol. 60, 216–223 (2012). This is a post hoc analysis of the ASTRONOMER study showing that metabolic syndrome is associated with faster progression of AS and that statins may accelerate the stenosis progression in these patients.
  Article PubMed Google Scholar
• Hekimian, G. et al. Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients — the COFRASA study. Eur. Heart J. 34, 1915–1922 (2013).
  Article CAS PubMed Google Scholar
• Briand, M. et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J. Am. Coll. Cardiol. 46, 291–298 (2005).
  Article PubMed Google Scholar
• Rieck, A. E. et al. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events. Hypertension 60, 90–97 (2012).
  Article CAS PubMed Google Scholar
• Cripe, L., Andelfinger, G., Martin, L. J., Shooner, K. & Benson, D. W. Bicuspid aortic valve is heritable. J. Am. Coll. Cardiol. 44, 138–143 (2004).
  Article PubMed Google Scholar
• Laforest, B., Andelfinger, G. & Nemer, M. Loss of Gata5 in mice leads to bicuspid aortic valve. J. Clin. Invest. 121, 2876–2887 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, L. M. et al. GATA5 loss-of-function mutations associated with congenital bicuspid aortic valve. Int. J. Mol. Med. 33, 1219–1226 (2014).
  Article CAS PubMed Google Scholar
• Foffa, I. et al. Sequencing of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes in familial cases of bicuspid aortic valve. BMC Med. Genet. 14, 44 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ducharme, V., Guauque-Olarte, S., Pibarot, P., Mathieu, P. & Bossé, Y. NOTCH1 genetic variants in patients with tricuspid calcific aortic valve stenosis. J. Heart Valve Dis. 22, 142–149 (2013).
  PubMed Google Scholar
• Guauque-Olarte, S. et al. Calcium signalings pathway genes RUNX2 and CACNA1C are associated with calcific aortic valve disease. Circ. Cardiovasc. Genet. 8, 812–822 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Smith, J. G. et al. Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. JAMA 312, 1764–1771 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Cowell, S. J. et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352, 2389–2397 (2005).
  Article CAS PubMed Google Scholar
• Rossebo, A. B. et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med. 359, 1343–1356 (2008). This is a randomized clinical trial that reports no effect of statins on the progression and the outcomes of calcific AS.
  Article PubMed Google Scholar
• Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A. & Tam, J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 121, 306–314 (2010).
  Article CAS PubMed Google Scholar
• Baumgartner, H. et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur. J. Echocardiogr. 10, 1–25 (2009).
  Article PubMed Google Scholar
• Pibarot, P. & Dumesnil, J. G. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J. Am. Coll. Cardiol. 60, 1845–1853 (2012). This is a review of the diagnosis and the management of low-flow, low-gradient AS, which is one of the most challenging entities in patients with valvular heart diseases.
  Article PubMed Google Scholar
• Nishimuram, R. A. & Carabello, B. A. Hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation 125, 2138–2150 (2012).
  Article Google Scholar
• Omran, H. et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361, 1241–1246 (2003).
  Article PubMed Google Scholar
• Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J. & Siscovick, D. S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Engl. J. Med. 341, 142–147 (1999).
  Article CAS PubMed Google Scholar
• Owens, D. S. et al. Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. J. Am. Coll. Cardiol. 5, 619–625 (2012).
  Article Google Scholar
• Lancellotti, P. et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 112, I377–I382 (2005).
  PubMed Google Scholar
• Maréchaux, S. et al. Usefulness of exercise stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur. Heart J. 31, 1390–1397 (2010).
  Article PubMed PubMed Central Google Scholar
• Monin, J. L. et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108, 319–324 (2003).
  Article PubMed Google Scholar
• Hachicha, Z., Dumesnil, J. G., Bogaty, P. & Pibarot, P. Paradoxical low flow low gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 115, 2856–2864 (2007).
  Article PubMed Google Scholar
• Blais, C. et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo Severe Aortic Stenosis) study. Circulation 113, 711–721 (2006).
  Article PubMed Google Scholar
• Clavel, M. A. et al. Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. J. Am. Soc. Echocardiogr. 23, 380–386 (2010).
  Article PubMed Google Scholar
• Tribouilloy, C. et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J. Am. Coll. Cardiol. 53, 1865–1873 (2009).
  Article PubMed Google Scholar
• Clavel, M. A. et al. Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF. JACC Cardiovasc. Imaging 6, 175–183 (2013).
  Article PubMed Google Scholar
• Clavel, M. A. et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined doppler-echocardiographic and computed tomographic study. J. Am. Coll. Cardiol. 62, 2329–2338 (2013). This is a multicentre study showing the usefulness of aortic valve calcium scoring by MDCT to corroborate the stenosis severity in patients with discordant findings at echocardiography.
  Article CAS PubMed Google Scholar
• Clavel, M. A. et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J. Am. Coll. Cardiol. 64, 1202–1213 (2014).
  Article PubMed PubMed Central Google Scholar
• Rosenhek, R. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N. Engl. J. Med. 343, 611–617 (2000).
  Article CAS PubMed Google Scholar
• Jenkins, W. S. et al. Valvular 18F-fluoride and 18F-fluorodeoxyglucose uptake predict disease progression and clinical outcome in patients with aortic stenosis. J. Am. Coll. Cardiol. 66, 1200–1201 (2015).
  Article PubMed Google Scholar
• Minners, J. et al. Inconsistent grading of aortic valve stenosis by current guidelines: haemodynamic studies in patients with apparently normal left ventricular function. Heart 96, 1463–1468 (2010).
  Article PubMed Google Scholar
• Dayan, V. et al. Outcome and impact of aortic valve replacement in patients with preserved LVEF and low-gradient aortic stenosis. J. Am. Coll. Cardiol. 66, 2594–2603 (2015).
  Article PubMed Google Scholar
• Hyafil, F. et al. Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. Am. J. Cardiol. 109, 1194–1196 (2012).
  Article PubMed Google Scholar
• Dweck, M. R. et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 125, 76–86 (2012).
  Article CAS PubMed Google Scholar
• Dweck, M. R. et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ. Cardiovasc. Imaging 7, 371–378 (2014). This study shows the use of sodium fluoride PET to detect the mineralization activity in the aortic valve and to predict the rapidity of aortic stenosis progression.
  Article PubMed Google Scholar
• Le Ven, F. et al. Valve tissue characterization by magnetic resonance imaging in calcific aortic valve disease. Can. J. Cardiol. 30, 1676–1683 (2014).
  Article PubMed Google Scholar
• Hope, M. D. et al. Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology 255, 53–61 (2010).
  Article PubMed Google Scholar
• Hope, M. D. et al. 4D flow CMR in assessment of valve-related ascending aortic disease. JACC Cardiovasc. Imaging 4, 781–787 (2011).
  Article PubMed Google Scholar
• Bartko, P. E. et al. Two-dimensional strain for the assessment of left ventricular function in low flow-low gradient aortic stenosis, relationship to hemodynamics and outcome: a substudy of the multicenter TOPAS study. Circ. Cardiovasc. Imaging 6, 268–276 (2012).
  Article PubMed Google Scholar
• Dahou, A. et al. Usefulness of global left ventricular longitudinal strain for risk stratification in low ejection fraction, low-gradient aortic stenosis: results from the multicenter true or pseudo-severe aortic stenosis study. Circ. Cardiovasc. Imaging 8, e002117 (2015).
  Article PubMed Google Scholar
• Lancellotti, P. et al. Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study. Eur. J. Echocardiogr. 11, 537–543 (2010).
  Article PubMed Google Scholar
• Dahl, J. S. et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ. Cardiovasc. Imaging 8, e002917 (2015).
  Article PubMed Google Scholar
• Lancellotti, P. et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am. J. Cardiol. 105, 383–388 (2010).
  Article CAS PubMed Google Scholar
• Ozkan, A., Kapadia, S., Tuzcu, M. & Marwick, T. H. Assessment of left ventricular function in aortic stenosis. Nat. Rev. Cardiol. 8, 494–501 (2011).
  Article PubMed Google Scholar
• Clavel, M. A. et al. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J. Am. Coll. Cardiol. 63, 2016–2025 (2014). This study shows the prognostic value of plasma BNP in patients with calcific AS. It also shows the importance of standardizing the measured level of BNP against the normal reference value for the patient's age and sex.
  Article CAS PubMed Google Scholar
• Weidemann, F. et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120, 577–584 (2009).
  Article CAS PubMed Google Scholar
• Azevedo, C. F. et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J. Am. Coll. Cardiol. 56, 278–287 (2010). This is one of the first studies to show the prognostic value of myocardial fibrosis measured by CMR in patients with calcific AS.
  Article PubMed Google Scholar
• Dweck, M. R. et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J. Am. Coll. Cardiol. 58, 1271–1279 (2011).
  Article PubMed Google Scholar
• Milano, A. D. et al. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. J. Thorac Cardiovasc. Surg. 144, 830–837 (2012).
  Article PubMed Google Scholar
• Herrmann, S. et al. Low-gradient aortic valve stenosis: myocardial fibrosis and its influence on function and outcome. J. Am. Coll. Cardiol. 58, 402–412 (2011).
  Article PubMed Google Scholar
• Nazarian, S. Is ventricular arrhythmia a possible mediator of the association between aortic stenosis-related midwall fibrosis and mortality? J. Am. Coll. Cardiol. 58, 1280–1282 (2011).
  Article PubMed Google Scholar
• Chin, C. W. et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur. Heart J. 35, 2312–2321 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Rosjo, H., Andreassen, J., Edvardsen, T. & Omland, T. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am. J. Cardiol. 108, 88–91 (2011).
  Article PubMed Google Scholar
• Chen, Z. et al. Circulating level of miR-378 predicts left ventricular hypertrophy in patients with aortic stenosis. PLoS ONE 9, e105702 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Rosjo, H. et al. Prognostic value of circulating microRNA-210 levels in patients with moderate to severe aortic stenosis. PLoS ONE 9, e91812 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Lindman, B. R. et al. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. Heart 101, 1382–1388 (2015).
  Article CAS PubMed Google Scholar
• Lindman, B. R., Bonow, R. O. & Otto, C. M. Current management of calcific aortic stenosis. Circ. Res. 113, 223–237 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Iung, B. et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur. Heart J. 26, 2714–2720 (2005).
  Article PubMed Google Scholar
• Leon, M. B. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Eng. J. Med. 363, 1597–1607 (2010). This randomized clinical trial shows the major superiority of TAVR compared with conservative management in patients who cannot undergo surgical AVR.
  Article CAS Google Scholar
• Lindman, B. R., Alexander, K. P., O'Gara, P. T. & Afilalo, J. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc. Interv. 7, 707–716 (2014). This review describes the challenges and strategies for decision-making in patients with severe calcific AS who are potential candidates for TAVR.
  Article PubMed PubMed Central Google Scholar
• Holmes, D. R. Jr, Rich, J. B., Zoghbi, W. A. & Mack, M. J. The heart team of cardiovascular care. J. Am. Coll. Cardiol. 61, 903–907 (2013).
  Article PubMed Google Scholar
• Holmes, D. R. Jr, Mohr, F., Hamm, C. W. & Mack, M. J. Venn diagrams in cardiovascular disease: the Heart Team concept. Eur. J. Cardiothorac Surg. 43, 255–257 (2013).
  Article PubMed Google Scholar
• Holmes, D. R. et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 59, 1200–1254 (2012).
  Article PubMed Google Scholar
• Levy, F. et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis: operative risk stratification and long-term outcome: a European multicenter study. J. Am. Coll. Cardiol. 51, 1466–1472 (2008).
  Article PubMed Google Scholar
• Harken, D. E. et al. Partial and complete prostheses in aortic insufficiency. J. Thorac Cardiovasc. Surg. 40, 744–762 (1960).
  CAS PubMed Google Scholar
• Lee, R. et al. Fifteen-year outcome trends for valve surgery in North America. Ann. Thorac Surg. 91, 677–684 (2011).
  Article PubMed Google Scholar
• Brown, J. M. et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac Cardiovasc. Surg. 137, 82–90 (2009).
  Article PubMed Google Scholar
• Hamm, C. W. et al. The German Aortic Valve registry (GARY): in-hospital outcome. Eur. Heart J. 35, 1588–1598 (2014).
  Article PubMed Google Scholar
• David, T. E., Woo, A., Armstrong, S. & Maganti, M. When is the Ross operation a good option to treat aortic valve disease? J. Thorac Cardiovasc. Surg. 139, 68–73 (2010).
  Article PubMed Google Scholar
• Stulak, J. M. et al. Spectrum and outcome of reoperations after the Ross procedure. Circulation 122, 1153–1158 (2010).
  Article PubMed Google Scholar
• David, T. E. Reoperations after the Ross procedure. Circulation 122, 1139–1140 (2010).
  Article PubMed Google Scholar
• Chiang, Y. P. et al. Survival and long-term outcomes following bioprosthetic versus mechanical aortic valve replacement in patients aged 50 to 69 years. JAMA 312, 1323–1329 (2014).
  Article CAS PubMed Google Scholar
• Brown, M. L., McKellar, S. H., Sundt, T. M. & Schaff, H. V. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. J. Thorac Cardiovasc. Surg. 137, 670–679 (2009).
  Article PubMed Google Scholar
• Astor, B. C., Kaczmarek, R. G., Hefflin, B. & Daley, W. R. Mortality after aortic valve replacement: results from a nationally representative database. Ann. Thorac Surg. 70, 1939–1945 (2000).
  Article CAS PubMed Google Scholar
• Ambler, G. et al. Generic, simple risk stratification model for heart valve surgery. Circulation 112, 224–231 (2005).
  Article PubMed Google Scholar
• Ashikhmina, E. A. et al. Aortic valve replacement in the elderly: determinants of late outcome. Circulation 124, 1070–1078 (2011).
  Article PubMed Google Scholar
• Bach, D. S. et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ. Cardiovasc. Qual. Outcomes 2, 533–539 (2009).
  Article PubMed Google Scholar
• Smith, C. R. et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364, 2187–2198 (2011).
  Article CAS PubMed Google Scholar
• Adams, D. H. et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N. Engl. J. Med. 370, 1790–1798 (2014). This randomized clinical trial shows the superiority of TAVR compared with surgical AVR in patients with intermediate or high surgical risk.
  Article CAS PubMed Google Scholar
• Kapadia, S. R. et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385, 2485–2491 (2015).
  Article PubMed Google Scholar
• Mack, M. J. et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385, 2477–2484 (2015).
  Article PubMed Google Scholar
• Popma, J. J. et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J. Am. Coll. Cardiol. 63, 1972–1981 (2014).
  Article PubMed Google Scholar
• Biere, L. et al. Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry. J. Am. Coll. Cardiol. 65, 755–757 (2015).
  Article PubMed Google Scholar
• Gilard, M. et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Eng. J. Med. 366, 1705–1715 (2012).
  Article CAS Google Scholar
• Ludman, P. F. et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) registry, 2007 to 2012. Circulation 131, 1181–1190 (2015).
  Article PubMed Google Scholar
• Holmes, D. R. et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA 313, 1019–1028 (2015).
  Article CAS PubMed Google Scholar
• Blackstone, E. H. et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral TAVR: a PARTNER-I trial substudy. Circulation 131, 1989–2000 (2015).
  Article PubMed Google Scholar
• Martinez-Clark, P. O. et al. Transcaval retrograde transcatheter aortic valve replacement for patients with no other access: first-in-man experience with CoreValve. JACC Cardiovasc. Interv 7, 1075–1077 (2014).
  Article PubMed Google Scholar
• Moat, N. E. et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis the U. K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J. Am. Coll. Cardiol. 58, 2130–2138 (2011).
  Article PubMed Google Scholar
• Walther, T. et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J. Am. Coll. Cardiol. 65, 2173–2180 (2015).
  Article PubMed Google Scholar
• Rodes-Cabau, J. Transcatheter aortic valve implantation: current and future approaches. Nat. Rev. Cardiol. 9, 15–29 (2012).
  Article Google Scholar
• Athappan, G. et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J. Am. Coll. Cardiol. 61, 1585–1595 (2013).
  Article PubMed Google Scholar
• Genereux, P. et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? A comprehensive review of the literature. J. Am. Coll. Cardiol. 61, 1125–1136 (2013).
  Article PubMed Google Scholar
• Pibarot, P., Hahn, R. T., Weissman, N. J. & Monaghan, M. J. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. JACC Cardiovasc. Imaging 8, 340–360 (2015).
  Article PubMed Google Scholar
• Kodali, S. et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur. Heart J. 36, 449–456 (2015).
  Article PubMed Google Scholar
• Van Belle, E. et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable TAVR procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 registry. Circulation 129, 1415–1427 (2014).
  Article PubMed Google Scholar
• Babaliaros, V. et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc. Interv. 7, 898–904 (2014).
  Article PubMed Google Scholar
• Dvir, D. et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA 312, 162–170 (2014).
  Article CAS PubMed Google Scholar
• Makkar, R. R. et al. Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. J. Am. Coll. Cardiol. 63, 901–911 (2014).
  Article PubMed Google Scholar
• Toggweiler, S. et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J. Am. Coll. Cardiol. 59, 2068–2074 (2012).
  Article PubMed Google Scholar
• Lindman, B. R. et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valves II inoperable cohort. Circ. Cardiovasc. Interv. 8, e002073 (2015).
  Article PubMed Google Scholar
• Reynolds, M. R. et al. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 124, 1964–1972 (2011).
  Article PubMed Google Scholar
• Reynolds, M. R. et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial (cohort A). J. Am. Coll. Cardiol. 60, 548–558 (2012).
  Article PubMed Google Scholar
• Svensson, L. G. et al. Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. J. Am. Coll. Cardiol. 64, 158–168 (2014).
  Article PubMed Google Scholar
• Goel, S. S. et al. Severe aortic stenosis and coronary artery disease — implications for management in the transcatheter aortic valve replacement era: a comprehensive review. J. Am. Coll. Cardiol. 62, 1–10 (2013).
  Article PubMed Google Scholar
• Stefanini, G. G. et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur. Heart J. 35, 2530–2540 (2014).
  Article PubMed Google Scholar
• Paradis, J. M. et al. Aortic stenosis and coronary artery disease: What do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. Eur. Heart J. 35, 2069–2082 (2014).
  Article PubMed Google Scholar
• Otto, C. M. et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 89, 642–650 (1994).
  Article CAS PubMed Google Scholar
• Kapadia, S. et al. Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER valve trial). JACC Cardiovasc. Interv. 8, 324–333 (2015).
  Article PubMed Google Scholar
• Otto, C. M. & Prendergast, B. Aortic-valve stenosis — from patients at risk to severe valve obstruction. N. Engl. J. Med. 371, 744–756 (2014).
  Article CAS PubMed Google Scholar
• Schwarz, F. et al. The effect of aortic valve replacement on survival. Circulation 66, 1105–1110 (1982).
  Article CAS PubMed Google Scholar
• Green, P. et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc. Interv. 5, 974–981 (2012).
  Article PubMed PubMed Central Google Scholar
• Schoenenberger, A. W. et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur. Heart J. 34, 692 (2013).
  Article CAS Google Scholar
• Stortecky, S. et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 5, 489–496 (2012).
  Article PubMed Google Scholar
• Mihaljevic, T. et al. Survival after valve replacement for aortic stenosis: implications for decision making. J. Thorac Cardiovasc. Surg. 135, 1270–1278 (2008).
  Article PubMed Google Scholar
• Kupari, M., Turto, H. & Lommi, J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur. Heart J. 26, 1790–1796 (2005).
  Article PubMed Google Scholar
• Dweck, M. R., Boon, N. A. & Newby, D. E. Calcific aortic stenosis: a disease of the valve and the myocardium. J. Am. Coll. Cardiol. 60, 1854–1863 (2012).
  Article PubMed Google Scholar
• Biner, S. et al. Prognostic value of E/E' ratio in patients with unoperated severe aortic stenosis. JACC Cardiovasc. Imaging 3, 899–907 (2010).
  Article PubMed Google Scholar
• Dewey, T. M. et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J. Thorac Cardiovasc. Surg. 135, 180–187 (2008).
  Article PubMed Google Scholar
• Lindman, B. R. et al. Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER trial (placement of aortic transcatheter valve). J. Am. Coll. Cardiol. 63, 1090–1099 (2014).
  Article PubMed Google Scholar
• Herrmann, H. C. et al. Predictors of mortality and outcomes of therapy in low flow severe aortic stenosis: a PARTNER trial analysis. Circulation 127, 2316–2326 (2013).
  Article PubMed Google Scholar
• Dvir, D. et al. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights for the PARTNER trial. J. Am. Coll. Cardiol. 63, 269–279 (2014).
  Article PubMed Google Scholar
• Mok, M. et al. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. JACC Cardiovasc. Interv. 6, 1072–1084 (2013).
  Article PubMed Google Scholar
• Rodes-Cabau, J. et al. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial. Circ. Cardiovasc. Interv 7, 701–711 (2014).
  Article PubMed Google Scholar
• Gjesdal, O., Bluemke, D. A. & Lima, J. A. Cardiac remodeling at the population level — risk factors, screening, and outcomes. Nat. Rev. Cardiol. 8, 673–685 (2011).
  Article PubMed Google Scholar
• Bull, S. et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 99, 932–937 (2013).
  Article PubMed Google Scholar
• Makkar, R. R. et al. Transcateter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366, 1696–1704 (2012).
  Article CAS PubMed Google Scholar
• Kodali, S. K. et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366, 1686–1695 (2012). This article reports the 2-year outcomes of the first randomized trial comparing transcatheter versus surgical AVR. This study shows that paravalvular regurgitation following TAVR is associated with increased risk of mortality.
• Webb, J. G. et al. A randomized evaluation of the SAPIEN XT transcatheter heart valve system in patients with aortic stenosis who are not candidates for surgery. JACC Cardiovasc. Interv. 8, 1797–1806 (2015).
  Article PubMed Google Scholar
• Kodali, S. & The PARTNER 3 TAVR Investigators. Clinical and echocardiographic outcomes at 30 days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS patients. J. Am. Coll. Cardiol. Abstr. press release [online] (2015).
• Herrmann, H. C. Evaluation of a balloon-expandable transcatheter aortic valve in high-risk and inoperable patients with aortic stenosis — one-year outcomes. J. Am. Coll. Cardiol. Abstr. [online] (2015).
• Reardon, M. J. et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 66, 113–121 (2015).
  Article PubMed Google Scholar
• Abdel-Wahab, M. et al. Comparison of balloon-expandable versus self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311, 1503–1514 (2014).
  Article CAS PubMed Google Scholar
• Thyregod, H. G. et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J. Am. Coll. Cardiol. 65, 2184–2194 (2015).
  Article PubMed Google Scholar
• US National Library of Science. The PARTNER II trial: Placement of AoRTic TraNscathetER Valves. ClinicalTrials.gov [online], (2011).
• US National Library of Science. Safety and efficacy study of the Medtronic CoreValve® system in the treatment of severe, symptomatic aortic stenosis in intermediate risk subjects who need aortic valve replacement (SURTAVI). ClinicalTrials.gov [online], (2012).